October 27, 2021
  • Centene’s CFO told inventors that the company will evaluate proposals from pharmacy benefits companies next year to manage the health insurer’s $30 billion per year drug spend. In 2018, Centene fired CVS Caremark as its PBM and shifted the drug purchasing functions to its own PBMs, RxAdvance and Envolve. Centene’s bid process will start next year, with a new PBM taking over by 2024. (Articles here and here)